Cargando…
DMF Activates NRF2 to Inhibit the Pro-Invasion Ability of TAMs in Breast Cancer
Tumor-associated macrophages (TAMs) account for more than 50% of the cells in the tumor immune microenvironment of patients with breast cancer. A high TAM density is associated with a poor clinical prognosis. Targeting TAMs is a promising therapeutic strategy because they promote tumor growth, devel...
Autores principales: | Li, Ying, Jia, Yaxu, Xu, Yurong, Li, Kan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406629/ https://www.ncbi.nlm.nih.gov/pubmed/34476214 http://dx.doi.org/10.3389/fonc.2021.706448 |
Ejemplares similares
-
The Nrf2 Activator (DMF) and Covid-19: Is there a Possible Role?
por: Hassan, Saif M., et al.
Publicado: (2020) -
TPL Inhibits the Invasion and Migration of Drug-Resistant Ovarian Cancer by Targeting the PI3K/AKT/NF-κB-Signaling Pathway to Inhibit the Polarization of M2 TAMs
por: Le, Fuyin, et al.
Publicado: (2021) -
Nrf2 Down-Regulation by Camptothecin Favors Inhibiting Invasion, Metastasis and Angiogenesis in Hepatocellular Carcinoma
por: Liu, Qian, et al.
Publicado: (2021) -
CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion
por: Gunaydin, Gurcan
Publicado: (2021) -
TAM-targeted reeducation for enhanced cancer immunotherapy: Mechanism and recent progress
por: Shen, Xinyuan, et al.
Publicado: (2022)